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Background: The qnr gene family consists of plasmid mediated
quinolone resistance (PMQR) genes that confer low level resistance
to nalidixic acid and reduced susceptibility to ciproﬂoxacin. At our
tertiary care referral centre in Chandigarh, which caters to a large
population of 5 neighboring states, antibiotic resistance in Shigella
is being constantly monitored
Methods & Materials: We screened 139 S.ﬂexneri and 38 S.
dysenteriae serotype 1 isolated during 2001 to 2011,for PMQR
(qnrA, qnrB, qnrS, aac(6′)-Ib-cr and qepA) genes. MICs were deter-
mined for nalidixic acid and ciproﬂoxacin by E-test. The isolates
were classiﬁed as susceptible (MICs <0.5mg/L) or resistant (MICs
≥1mg/L) to ciproﬂoxacin; susceptible (MIC ≤ 16) or resistant (MIC
≥ 32) to nalidixic acid respectively. Those positive for PMQR were
tested for ESBL (CLSI).
Results: Eleven (6.12%) isolates, were found to harbor PMQR,
out of which 2 were positive for qnrS1 gene (S. ﬂexneri),while
9 for aac(6′)-Ib-cr gene (6 S. ﬂexneri and 3 S. dysenteriae). No
strain harbored both genes. None were positive for qnrA, qnrB,
qnrD and qepA genes. Out of 11 PMQR positive isolates, 3 showed
ciproﬂoxacin MIC of ≥32mg/L while 9 strains were resistant to
nalidixic acid with a MIC of > 128mg/L, 3 were positive for CTX-
M-15 and 1 for CMY-2 gene. The aac(6′)-Ib-cr gene was detected as
early as 2002,combination of CTXM-15with aac(6′)-Ib-cr appeared
in 2005 and qnrS1 appeared recently in 2010. PMQR could not be
the direct reason for quiniolone and ﬂuoroquinolone resistance in
these strains. Sequencing of gyrA and parC revealed three muta-
tions on the QRDR of each of the 11 PMQR positive strains, thought
to be primarily responsible for quinolone resistance phenotype
Conclusion: After description of qnrS1 Shigella in Japan, China
and USA, we report the ﬁrst description of qnrS1 Shigella in India.
Furthermore, combination of PMQR and CTXM-15 genes is being
reported here for the ﬁrst time in Shigella. The close association
of aac(6′)-Ib-cr, with CTX-M-15 is of great concern as CTX- M-
15 has emerged worldwide. The two qnrS1 strains detected were
from 2010, indicating a relatively new appearance among Shigella
in India.
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H1N1 - Monster to be tamed
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Background: There is an increase in H1N1 patients in our
community leading to morbidity and mortality. This study aimed
to assess the epidemiology and characteristics of H1N1 patients
requiring intensive care unit admission.
Methods & Materials: The retrospective cohort study included
14 H1N1 patients admitted in ICU from November, 2014 to April,
2015. Data was analyzed from patient’s medical records. All ICU
patients who were tested positive for H1N1 by reverse – tran-
scriptasepolymerase– chain reaction assaywere included. Patients
treated for H1N1 in the ward and out – patient department were
excluded. Categorical variableswere compared using Fisher’s exact
test.
Results: In our study, the mean standard error (SE) age was
46.85 (3.85) years and male to female distribution was equal.
Majority of the patients presented with dry cough (85.7%), dysp-
nea (78.6%) and fever (71.4%) on ICU admission. 92.8% patients had
moderate to severe adult respiratory distress syndrome. Sequential
organ severity assessment scorewas less than11 for 92.8%patients.
Non- invasive ventilation (NIV) was initiated on 78.6% patients and
6 (42.8%) patients improved on NIV alone. Eight (57.1%) patients
needed invasive ventilation and all ventilated patients required
prone ventilation within 24 hours. Mean duration of mechanical
ventilation was 23.5 (7.21) days and mean duration of prone venti-
lation was 5.5 (2) days. Tracheostomy was done in 21.4% patients.
Complication during ICU stay included ventilator associated pneu-
monia (75%), critical illness polyneuropathy (12.5%), acute kidney
injury (14.3%) andpneumothorax (7.1%).Meandays of ICU staywas
14.7 (4.27) days and mean duration of hospitalization was 23.07
(7.61) days. The 30 days survival rate in our study was 64.3% and
mortality was attributed to severe refractory hypoxemia.
Conclusion:H1N1patients areunique inpresentationandman-
agement. There is a need for awareness and education for early
initiation of Oseltamivir at primary care centers to reduce the
severity of H1N1. The patients required longer ventilation and
all ventilated patients required prone ventilation. Extra corporeal
membrane oxygenation could be considered as rescue therapy in
severely hypoxic patients.
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